Last reviewed · How we verify
Hurthle cell carcinoma of thyroid
Approved treatments
- Lenvima · Eisai
Lenvima works by blocking the activity of a specific protein called Ret, which is involved in the growth and spread of cancer cells.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Hurthle cell carcinoma of thyroid patent landscape — cliff calendar, originator estates, attackable patents
- Hurthle cell carcinoma of thyroid treatment landscape brief
- Hurthle cell carcinoma of thyroid treatment updates RSS
Frequently asked questions about Hurthle cell carcinoma of thyroid
What drugs treat Hurthle cell carcinoma of thyroid?
Tracked treatments include Lenvima.
What is the treatment for Hurthle cell carcinoma of thyroid?
Standard treatment for Hurthle cell carcinoma of thyroid includes Lenvima. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Hurthle cell carcinoma of thyroid patent cliff · Hurthle cell carcinoma of thyroid CI report
- Treatment: Lenvima · Eisai
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing